Literature DB >> 9032198

Directly observed isoniazid preventive therapy for released jail inmates.

C M Nolan1, L Roll, S V Goldberg, A M Elarth.   

Abstract

This study was designed to determine whether an integrated screening program could be implemented that identified persons with latent tuberculosis infection among jail inmates and produced a high rate of completion of isoniazid preventive therapy (IPT) in those persons after their discharge from short-term detention, by means of community-based directly observed preventive therapy (DOPT). From June 1, 1992 through December 31, 1994 inmates in the King County Jail who were from populations at high risk of tuberculosis were screened by means of the tuberculin skin test and those with latent tuberculosis infection were offered IPT. Among 262 inmates receiving IPT upon release from jail, 105 (40%) could not be located after release. Among another 105 enrolled on DOPT, 63 (60%) completed therapy. Among 52 who chose self-supervised isoniazid therapy after release, 15 (29%) completed therapy (chi-square = 13.50, p = 0.0002). Among persons with latent tuberculosis infection detected during screening at a county jail, a postrelease DOPT program resulted in a high rate of immediate loss to follow-up and a low rate of completion of therapy. Based on these results, we suggest that funds for TB control, if limited, should not be diverted to jail-based screening and postrelease DOPT.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032198     DOI: 10.1164/ajrccm.155.2.9032198

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  8 in total

1.  Prevalence of tuberculosis symptoms and latent tuberculous infection among prisoners in northeastern Malaysia.

Authors:  B Margolis; H A A Al-Darraji; J A Wickersham; A Kamarulzaman; F L Altice
Journal:  Int J Tuberc Lung Dis       Date:  2013-12       Impact factor: 2.373

2.  Risk factors for treatment default in close contacts with latent tuberculous infection.

Authors:  C T Fiske; F-X Yan; Y Hirsch-Moverman; T R Sterling; M R Reichler
Journal:  Int J Tuberc Lung Dis       Date:  2014-04       Impact factor: 2.373

3.  Assessment of tuberculosis screening and management practices of large jail systems.

Authors:  Audrey A Reichard; Mark N Lobato; Cheryl A Roberts; Lauri B Bazerman; Theodore M Hammett
Journal:  Public Health Rep       Date:  2003 Nov-Dec       Impact factor: 2.792

4.  Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: a controlled trial.

Authors:  Melbourne F Hovell; Carol L Sipan; Elaine J Blumberg; C Richard Hofstetter; Donald Slymen; Lawrence Friedman; Kathleen Moser; Norma J Kelley; Alicia Y Vera
Journal:  Am J Public Health       Date:  2003-11       Impact factor: 9.308

5.  A situational analysis of latent tuberculosis infection among incarcerated population in Japan.

Authors:  Lisa Kawatsu; Kazuhiro Uchimura; Akihiro Ohkado
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

6.  Evaluation of the isoniazid preventive therapy (IPT) program in Shurugwi District, Midlands Province, Zimbabwe, January 2013 to August 2014.

Authors:  Annamercy Makoni; Milton Chemhuru; Mufuta Tshimanga; Notion Tafara Gombe; More Mungati; Donewell Bangure
Journal:  BMC Res Notes       Date:  2015-09-25

7.  Impact of latent infection treatment in indigenous populations.

Authors:  Lucia Suemi Yuhara; Flávia Patussi Correia Sacchi; Julio Croda
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

8.  Initiation and completion rates for latent tuberculosis infection treatment: a systematic review.

Authors:  Andreas Sandgren; Marije Vonk Noordegraaf-Schouten; Femke van Kessel; Anke Stuurman; Anouk Oordt-Speets; Marieke J van der Werf
Journal:  BMC Infect Dis       Date:  2016-05-17       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.